Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;6(2):219-33.
doi: 10.1007/s13555-016-0098-5. Epub 2016 Feb 17.

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Affiliations

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Alison Layton et al. Dermatol Ther (Heidelb). 2016 Jun.

Erratum in

Abstract

Introduction: Scarring on visible areas such as the face is associated with negative psychological impact. Many patients with acne have clinically relevant scarring for which they seek treatment, implying that there is an impact on their lives. Currently there are no validated tools to assess the burden of atrophic acne scarring from the patient's perspective or to assess treatment benefit.

Methods: Two patient-reported outcome measures, the self-assessment of clinical acne-related scars (SCARS) and the facial acne scar quality of life (FASQoL) tools, both specific to facial atrophic acne scarring, were developed according to Food and Drug Administration guidance methodology. Patient interviews were conducted first to elicit patient-important concepts about scarring, then to validate patients' understanding of wording in the tools. These tools focus on symptoms (SCARS) and psychological and social well-being (FASQoL) and were designed to be suitable for self-completion and to be rapidly completed (2-5 min) within a clinical research setting.

Results: Concept elicitation interviews were conducted with 30 subjects and cognitive interviews with 20 subjects. With acne scarring, important concepts for patients included size, surface area affected, counts, and depth. The SCARS and FASQoL tools were shown to address relevant concepts that were easily understood by patients.

Conclusion: Two patient-reported measures, SCARS and FASQoL, have been developed to help clinicians assess the severity and impact of acne scars. Responsivity of these instruments to treatment will require further evaluation.

Funding: Galderma R&D, Sophia Antipolis, France.

Keywords: Acne; Atrophic scar; Patient-reported outcome measure; Quality of life; Scar assessment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Methodology for developing patient-reported outcomes tool
Fig. 2
Fig. 2
Factors patients identified important in determining acne scar severity
Fig. 3
Fig. 3
Concepts most bothersome to acne scar subjects

References

    1. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303–308. doi: 10.1111/j.1365-2230.1994.tb01200.x. - DOI - PubMed
    1. Tan JK, Tang J, Fung K, Gupta AK, Richard Thomas D, Sapra S, et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg. 2010;14:156–160. doi: 10.2310/7750.2010.09037. - DOI - PubMed
    1. Kantar Health Inc. Acne Scars Report 26 April 2013.
    1. Goodman GJ. Management of post-acne scarring. What are the options for treatment? Am J Clin Dermatol. 2000;1:3–17. doi: 10.2165/00128071-200001010-00001. - DOI - PubMed
    1. Dreno B, Khammari A, Orain N, et al. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology. 2007;214:46–51. doi: 10.1159/000096912. - DOI - PubMed

LinkOut - more resources